Fig. 1

Crude and age-standardized CVE prevalence ratios for MLSP patients with SLE, overall and by subgroup. Figure 1 footnote 1: NYCHANES data from 2013–2014, NHANES data from 2009–2010 MLSP, 2007 among Manhattan Residents. Figure 1 footnote 2: Prevalence estimates for those identified as non-Hispanic Asian and non-Hispanic other were not included, as they were either not available from the data source (NHANES) or estimates were unreliable (NYC HANES). However, they were not excluded from total or sex-specific ratios presented. Age-standardized prevalence ratios (ASPR) were calculated based on prevalence of heart attack or stroke among three age groups (20–39, 40–59, 60+)